Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Hutchmed (HCM) Share News

Hutchison China MediTech Surufatinib Cancer Study Doses First Patient

29th Mar 2019 09:16

LONDON (Alliance News) - Biopharmaceutical firm Hutchison China MediTech Ltd on Friday said it has begun a study of cancer drug surufatinib in patients with advanced biliary tract biliary tract by Read More

Hutchison China Meditech 2018 Loss Widens On New Government Policy

11th Mar 2019 08:45

LONDON (Alliance News) - Hutchison China Meditech Ltd on Monday said its loss widened in 2018 as sales decreased following an implementation of new government policy in China.The company to Read More

Hutchison China Meditech Starts Fruquintinib Capsules Sales In China

26th Nov 2018 08:35

LONDON (Alliance News) - Hutchison China Meditech Ltd on Monday said it launched fruquintinib capsules Elunate with the initiation of product sales in China.Elunate is used for the of with Read More

SVM UK Emerging Fund Beats Benchmark With Three Key Holdings

19th Nov 2018 19:02

LONDON (Alliance News) - SVM UK Emerging Fund PLC on Monday said it had outpaced its benchmark in its most recent half year due to strong performances from three key holdings.As at 30, the Read More

Hutchison China Meditech Starts Phase I Study For Leukemia In China

18th Oct 2018 10:09

LONDON (Alliance News) - Hutchison China Meditech Ltd said Thursday it commenced a phase I study of HMPL-523 to treat elderly patients with acute myeloid leukemia in China.The aim of the is Read More

Hutchison Gains Fruquintinib Capsules Approval As Cancer Drug In China

5th Sep 2018 08:28

LONDON (Alliance News) - Hutchison China Meditech Ltd said Wednesday it gained Chinese approval for its Fruquintinib capsules to be used as treatment for metastatic colorectal cancer.The of Read More

Hutchinson China Meditech Swings To Net Loss, Ups Annual Loss Estimate

27th Jul 2018 08:54

LONDON (Alliance News) - Hutchison China Meditech Ltd on Friday raised its annual loss estimate by USD20 million after swinging to an interim net loss.For the six months to June 30, the a a Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

20th Jul 2018 15:50

Monday 23 July Ryanair HoldingsQ1 ResultsAscentialHalf Year Retail GroupHalf 24 Read More

Hutchison China Cancer Trial Shows Clinically Meaningful Benefits

4th Jun 2018 11:11

LONDON (Alliance News) - Biopharmaceutical company Hutchison China MediTech Ltd said Monday patients in its FRESCO Phase III study "demonstrated a statistically significant and clinically at Read More

UK Shareholder Meetings Calendar - Next 7 Days

20th Apr 2018 15:00

Monday 23 AprilForeign & Colonial Investment Trust BioquellMicrogenHgCapital Read More

Hutchison China Meditech 2017 Loss Widens Amid Rising Research Costs

12th Mar 2018 08:53

LONDON (Alliance News) - China-focused drug developer and distributor Hutchison China Meditech PLC said Monday annual losses widened due to increased and Read More

Hutchison China Meditech Begins New Study For Epitinib Treatment

6th Mar 2018 09:44

LONDON (Alliance News) - Pharmaceutical firm Hutchison China Meditech Ltd has started a phase Ib/II proof-of-concept study for its proposed brain cancer treatment is being in Read More